INTOMEDI FIRST AMPOULE PEPTIDE

Manufacturer
Janytree Inc.
Effective date
2022-07-12
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:50:09

Label at a glance#

ProductINTOMEDI FIRST AMPOULE PEPTIDE
Active ingredientHYALURONATE SODIUM
Label structure8 sections

Label contents#

Full prescribing information#

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Water, Ethyl Ascorbyl Ether, Dipropylene Glycol, Butylene Glycol, Glycerin, 1,2-Hexanediol, Lactobacillus
/Hydrolyzed Pea Seed Extract Ferment Filtrate(Bio-Peptone®), Dimethyl Sulfone, Snail Secretion Filtrate,
Panthenol, Centella Asiatica Extract, Pentylene Glycol, Ethyl Hexanediol, Mentha Piperita (Peppermint)
Extract, Phenoxyethanol, Hydrolyzed Collagen, Allantoin, Polygonum Cuspidatum
Root Extract, Scutellaria Baicalensis Root Extract, Camellia Sinensis Leaf Extract, Glycyrrhiza Glabra
(Licorice) Root Extract, Sodium Hyaluronate Crosspolymer, Rosmarinus Officinalis (Rosemary) Leaf
Extract, Chamomilla Recutita (Matricaria) Flower Extract, Nicotinoyl Hexapeptide-44, Caffeoyl
sh-Decapeptide-9, sh-Oligopeptide-1(EGF), sh-Oligopeptide-2(IGF), sh-Polypeptide-64(AQP)

ACTIVE INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

Sodium Hyaluronate

OTC - PURPOSE SECTION

A powerful multi-peptide ampoule for hydrating and glowing skin.
Formulated with 5 kinds of peptide and 2 kinds of hyaluronic acid

WARNINGS

WARNINGS SECTION

For external use only When using this product
■ If following abnormal symptoms occurs after using the product, stop using the product and consult with a skin specialist. Symptoms : Red specks, swelling, itching
■ Do not use on the skin parts affected by wound, eczema, or dermatitis.
Keep out of reach of children.
■ If swallowed, get a medical help or contact a person in control center immediately.
■ Avoid contact with eyes.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN

If swallowed, get a medical help or contact a person in control center immediately.

INDICATIONS & USAGE SECTION

After cleansing, apply an appropriate amount to entire face or any area needing
treated. Massage gently until it is fully absorbed into the skin.

DOSAGE & ADMINISTRATION SECTION

for external use only

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabel

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
82879-0006-22025-01-30C16284748780-12cef2736-8b71-d83d-e063-dadaa90ab31fe3a7d5d1-46b5-a5ca-e053-2a95a90aea94

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
82879-0006-1INTOMEDI FIRST AMPOULE PEPTIDE5 mL in 1 BOTTLELIQUID51
82879-0006-2INTOMEDI FIRST AMPOULE PEPTIDE5 in 1 PACKAGELIQUID51

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
82879-0006INTOMEDI FIRST AMPOULE PEPTIDE (SODIUM HYALURONATE) LIQUID [JANYTREE INC.]1Legacy NDC, 2 package rows20220714_e3a7d5d1-46b5-a5ca-e053-2a95a90aea94.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
82879-000682879-0006-1, 82879-0006-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
e3a7d79b-d06b-9547-e053-2995a90a2712e3a7d5d1-46b5-a5ca-e053-2a95a90aea942022-07-12WarningsExact identifier
spl id: e3a7d79b-d06b-9547-e053-2995a90a2712
spl set id: e3a7d5d1-46b5-a5ca-e053-2a95a90aea94

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.